Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1970 Apr 18;2(5702):131-6.
doi: 10.1136/bmj.2.5702.131.

Bone marrow graft in man after conditioning by antilymphocytic serum

Bone marrow graft in man after conditioning by antilymphocytic serum

G Mathé et al. Br Med J. .

Abstract

Allogeneic bone marrow grafts carried out after previous administration of antilymphocytic serum alone were attempted in 16 patients. Of these, six had acute myeloblastic leukaemia, four acute lymphoblastic leukaemia, and one a blast cell crisis in polycythaemia vera. Ten of these patients were in an overt phase of the disease and resistant to chemotherapy, while nine had complete agranulocytosis. In five of these patients erythrocyte and leucocyte antigenic markers demonstrated the establishment of the graft. One patient had thalassaemia major, and four others had aplasia of the bone marrow, in one case due to chloramphenicol poisoning and in another to virus hepatitis. The grafts were successful in the last two patients and transformed their clinical condition.No signs of early acute secondary disease were noted in any of the patients, either when the donor had been given antilymphocytic serum or when he was untreated. The grafts had no adoptive immunotherapeutic effect on the acute leukaemia. These observations have clearly shown that antilymphocytic serum has an immunosuppressive effect in man when it is used alone.

PubMed Disclaimer

References

    1. Proc Soc Exp Biol Med. 1958 Dec;99(3):651-3 - PubMed
    1. Lancet. 1968 Dec 28;2(7583):1364-6 - PubMed
    1. Blood. 1965 Feb;25:179-96 - PubMed
    1. Lancet. 1969 Jan 4;1(7584):18-21 - PubMed
    1. Nouv Rev Fr Hematol. 1961 Jan-Feb;1:65-71 - PubMed